IGF-1 receptor activation drives cellular proliferation broadly - not just in muscle
When administered via injection, SLU-PP-332 demonstrates: Rapid absorption into the bloodstream High bioavailability, with a significant portion of the drug reaching systemic circulation Consistent absorption patterns across different patient populations These absorption characteristics contribute to the potential efficacy of SLU-PP-332 in various therapeutic applications
Application Areas: Metabolic Disease Research: Obesity, insulin resistance, type 2 diabetes mechanism and drug development Aging and Longevity Research: NAD+ homeostasis, mitochondrial function, regulation of cell aging pathways Neuroscience Research: Exploration of protective effects on neurodegenerative diseases such as Parkinsons disease Sports Science: Enhancing endurance, promoting muscle repair and improving physical performance research
NAD+ declines naturally with age, contributing to reduced cellular function, decreased energy production, and impaired DNA repair
The technical definition according to Lehningers Principles of Biochemistry is that pH is equal to the negative logarithm of hydrogen ion concentration in a solution
Research-only note: 5-Amino-1MQ is not FDA-approved for therapeutic use